Densitas® is a provider of artificial intelligence solutions for mammography and breast cancer screening designed to reduce health care costs and increase quality and appropriateness of care. Densitas® designs solutions that align with value-based care delivery models, focussing on precision breast health, mammography quality, workflow efficiencies, national mammography reporting standards, FDA MQSA EQUIP compliance, and radiological technologist performance evaluation and tailored educational content.
densitas® intelliMammo™ provides advanced embedded analytics to enable benchmarking, monitoring, trend-detection, and corrective actions based on analysis of routinely archived prior mammograms and newly acquired mammograms.
densitas® densityai™ automatically provides breast density assessments in alignment with ACR 5th ed. guidance.
densitas® qualityai™ provides standardized clinical image quality evaluations on every mammogram taken across health systems.
densitas® riskai™ automatically generates short-term personalized risk assessments using only image-derived risk factors from standard DICOM images.
Consider a health system with 100,000 women who start annual screening at 50 years old and regularly participate in a breast cancer screening program for the whole of their lives. A health economics headroom analysis in the US market shows the following lifetime cost savings:
The rise in burnout amongst radiologists is a global phenomenon, and is especially prominent in breast imaging.
Long gone are the days when fears that A.I. will replace radiologists dominated the discourse.
According to one survey, 70% of healthcare institutions already have or are planning to introduce A.I. into their everyday practices. There is a growing recognition of A.I.’s potential to alleviate some of the most pressing challenges clinicians face daily, including physician burnout and cost-effective service delivery while maintaining quality and improving clinical outcomes.
Now, COVID-19 is adding unprecedented pressures to healthcare systems around the world. Physician burnout existed long before COVID-19, and it will get much worse as healthcare workers fight COVID-19 by necessarily prioritizing the critically ill. Unfortunately the growing backlog of medical procedures and exams will make the situation worse.
Delivering a high standard of care with the same or fewer resources at a time when the growing backlog of women requiring breast screening exams will overwhelm health systems stretched to their limits and promises to have a long-lasting impact on the mental health of our care providers.
Densitas® Inc., a global provider of A.I. technologies for digital mammography and breast screening, announced today their partnership with Mammography Educators to offer the first artificial intelligence powered telehealth technologist training platform to support business continuity in mammography facilities.
Densitas® Inc., a leading provider of A.I. technologies for digital mammography and breast screening, announced today that NorthShore University HealthSystem (NorthShore), will deploy the densitas® intelliMammo™ platform across its mammography facilities. With this deployment, breast density, clinical image quality, and breast cancer risk assessments will be automatically generated for every mammogram taken throughout the health system.
AI has the potential to deliver significant benefits to populations and health systems when used appropriately.
However, the development and application of AI poses unique challenges that require a thoughtful response to ensure appropriateness of use.